Fennec Pharmaceuticals logo

FENC Fennec Pharmaceuticals

Fennec Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in the development of sodium thiosulfate for the prevention of ototoxicity from cisplatin in pediatric cancer patients. The company was founded by Orest W. Blaschuk on September 3, 1996 and is headquartered in Durham, NC.

Healthcare Biotechnology SIC: Unknown CIK: 1211583 

Login to follow FENC

Transaction DateRecipientSharesTypePriceValue
Jodie Insights Rating